Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Alzamend Neuro, Inc. - Common Stock (NQ:ALZN)

2.490 -0.120 (-4.60%)
Streaming Delayed Price Updated: 2:46 PM EDT, Oct 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 74,146
Open 2.660
Bid (Size) 2.450 (4)
Ask (Size) 2.490 (7)
Prev. Close 2.610
Today's Range 2.458 - 2.680
52wk Range 2.060 - 15.21
Shares Outstanding 3,139,861
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Hewlett Packard Enterprise To Rally Around 33%? Here Are 10 Top Analyst Forecasts For Thursday
 
Via Benzinga
Alzamend Neuro to Present at the 2025 Military Health System Research Symposium
From Alzamend Neuro, Inc.
Via GlobeNewswire

Performance

YTD
-76.9%
-76.9%
1 Month
+4.6%
+4.6%
3 Month
+10.7%
+10.7%
6 Month
-58.4%
-58.4%
1 Year
-82.3%
-82.3%

More News

Read More
Alzamend Neuro Reports Annual 2025 Financial Results and Provides Update on Clinical Programs
From Alzamend Neuro, Inc.
Via GlobeNewswire
Alzamend Neuro Announces Final Closing of $5 Million Private Placement Months Ahead of Schedule
From Alzamend Neuro, Inc.
Via GlobeNewswire
Which stocks are experiencing notable movement on Friday?
Via Chartmill
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Top movers in Friday's session
Via Chartmill
Traders are paying attention to the gapping stocks in Friday's session.
Via Chartmill
Synergy CHC Corp. (NASDAQ: SNYR) Taps Beverage Veteran to Drive FOCUSfactor’s Drink Expansion – More Stocks Inside
Via AB Newswire
Topics Economy
Let's take a look at the stocks that are in motion in today's session.
Via Chartmill
Alzamend Neuro Stock Rockets On Dosing Of First Human Patient With Lithium-Delivery System AL001 In Phase II Study: Retail’s Thrilled
Via Stocktwits
Alzamend Neuro (ALZN) Stock Surges On AL001 Phase II Trial Milestone
Via Benzinga
Crude Oil Falls Over 1%; Best Buy Reports Downbeat Results
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Keep an eye on the top gainers and losers in Thursday's session.
Via Chartmill
The market is filled with gapping stocks in Thursday's session.
Via Chartmill
Alzamend Neuro Inc. (NASDAQ: ALZN) Targets Transformative Mental Health Breakthroughs
Via Investor Brand Network
Topics Artificial Intelligence
Nasdaq Gains Over 1%; Nvidia Posts Strong Revenue
Via Benzinga
BioMedNewsBreaks — Alzamend Neuro, Inc. (NASDAQ: ALZN) Doses First Patient in Phase II Trial for Next-Gen Lithium Therapy AL001
Via Investor Brand Network
What's going on in today's pre-market session
Via Chartmill
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Alzamend Neuro Announces Dosing of First Patient in its Phase II Clinical Trial of AL001 “Lithium in Brain” Study Taking Place at Massachusetts General Hospital
From Alzamend Neuro, Inc.
Via GlobeNewswire
Alzamend Neuro Enrolls First Patient in its Phase II Clinical Trial of AL001 “Lithium in Brain” Study Taking Place at Massachusetts General Hospital
From Alzamend Neuro, Inc.
Via GlobeNewswire
Which stocks are moving before the opening bell on Tuesday?
Via Chartmill
Alzamend Neuro Initiates First Phase II Clinical Trial of AL001 “Lithium in Brain” Study Taking Place at Massachusetts General Hospital
From Alzamend Neuro, Inc.
Via GlobeNewswire

Frequently Asked Questions

Is Alzamend Neuro, Inc. - Common Stock publicly traded?
Yes, Alzamend Neuro, Inc. - Common Stock is publicly traded.
What exchange does Alzamend Neuro, Inc. - Common Stock trade on?
Alzamend Neuro, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Alzamend Neuro, Inc. - Common Stock?
The ticker symbol for Alzamend Neuro, Inc. - Common Stock is ALZN on the Nasdaq Stock Market
What is the current price of Alzamend Neuro, Inc. - Common Stock?
The current price of Alzamend Neuro, Inc. - Common Stock is 2.490
When was Alzamend Neuro, Inc. - Common Stock last traded?
The last trade of Alzamend Neuro, Inc. - Common Stock was at 10/31/25 02:46 PM ET
What is the market capitalization of Alzamend Neuro, Inc. - Common Stock?
The market capitalization of Alzamend Neuro, Inc. - Common Stock is 7.82M
How many shares of Alzamend Neuro, Inc. - Common Stock are outstanding?
Alzamend Neuro, Inc. - Common Stock has 8M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.